Job at a glance
About Synapticure Synapticure is the largest, most comprehensive specialty care and life sciences company in the country for those living with neurodegenerative diseases. Founded by patients and caregivers living with these diseases, we are redefining the care and the research paradigm for conditions like Alzheimer's, Parkinson's, and ALS in all 50 states. Our business is powered by two connected engines.
The CARES Engine (Clinical Operations) A scalable, 50-state virtualized clinical network providing timely access to expert neurologists and cutting edge treatments with wraparound care coordination and behavioral health support. Our team creates personalized care plans focused on education and empowerment, connecting patients with a multidisciplinary team of subspecialty neurologists, geriatricians, psychologists, and care coordinators who collaborate to deliver comprehensive care.
The CURES Engine (Research & Innovation) Leveraging our deeply engaged, well characterized national patient cohort, CURES partners with life science, pharma, biotech, and medical device companies to accelerate the development of neurodegenerative treatments, spanning discovery stage lab services, clinical trial services, and real world evidence data and analytics. Partnering with providers, health plans, and life sciences companies, including CMS' GUIDE dementia care model, Synapticure is dedicated to transforming the lives of millions of individuals and their families living with neurodegenerative diseases.
About the Role The Life Sciences Growth Director owns revenue generation for Synapticure’s Research business lines, with primary focus on Clinical Research and Real-World Evidence (RWE) offerings sold into pharmaceutical and biotechnology partners. This is a hands-on, quota-carrying role: sourcing, qualifying, shaping, and closing research engagements with sponsors, and expanding them over time. Beyond direct pharma sales, the role extends into the broader research funding ecosystem — research-granting and advocacy foundations (e.g., The Michael J.
Fox Foundation, ALS Association, Alzheimer’s Association, Huntington’s Disease Society of America) and contract research organizations (CROs), which represent both customers and channel partners. This role is also expected to contribute meaningfully to what we sell, not just how much. The Director will work with clinical, data, and operations leadership to shape the design, packaging, and pricing of Synapticure’s research services and products, bringing market signal from live deals back into product strategy.
The Day to Day Sales Execution — Research Business Lines (Primary) Carry and deliver against an annual bookings and revenue target for Clinical Research and RWE services sold to pharmaceutical and biotechnology partners. Build and maintain a qualified pipeline through prospecting, outbound targeting of sponsor teams (clinical development, medical affairs, HEOR/RWE, patient recruitment, data science, and neuroscience therapeutic area leadership), conference-based sourcing, and expansion within existing accounts.
Lead the full deal cycle — discovery, solutioning, proposal and SOW development, pricing, negotiation, and close — coordinating internal subject-matter experts as needed. Develop account plans for priority sponsors, including stakeholder mapping across therapeutic areas and functions, and multi-year expansion paths from initial engagement to enterprise relationship. Partner with clinical operations, data, and finance teams to scope engagements accurately and price them to protect margin and deliverability.
Maintain disciplined CRM hygiene, accurate forecasting, and clear pipeline reporting to the SVP and executive team. Represent Synapticure at industry conferences, sponsor meetings, and partner forums. In scope where appropriate: sales of Synapticure’s laboratory and diagnostic services, either standalone or as a component of broader research engagements. Foundations, CROs, and the